This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Increasing sales is vital for profitability. Learn effective techniques to boost sales and enhance your profits.
28,655 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Global defense markets are shifting as high-tech anti-armor systems change battlefield economics. Investors are watch...
Investors eyeing SPRY's Q1 2026 results should understand how to parse a pharma earnings transcript. This guide break...
Geopolitical tensions around Iran are pushing oil volatility and, in turn, accelerating EV adoption. Analysts warn th...
Tanger Outlets, a leading retail REIT, reports a rebound in shopper traffic and demand across its outlet centers in e...
In 2026, investors face a critical choice between a clinical-stage biotech and a cash-flow powerhouse. This guide com...
Daryl Hannah publicly refutes decades of rumors about her life with JFK Jr., spotlighting how reputational storms rip...
As military spending climbs worldwide, select defense stocks poised benefit due to diversified portfolios, strong cas...
Plug Power recently beat quarterly estimates, but that isn’t a guarantee the stock is safe to buy. This guide breaks ...
Nvidia sits at the center of AI-driven growth. This guide examines potential price paths for what will nvidia stock's...
January 2026 brings a shift in power toward buyers. Homes stay on the market longer, and sellers are more willing to ...
The Fed’s decision to hold rates steady sent ripples through the market as inflation worries resurfaced. Here’s what ...